U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019082

Expand all

DALGAN (DEZOCINE)
5MG/ML
Marketing Status: Discontinued
Active Ingredient: DEZOCINE
Proprietary Name: DALGAN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019082
Product Number: 001
Approval Date: Dec 29, 1989
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
DALGAN (DEZOCINE)
10MG/ML
Marketing Status: Discontinued
Active Ingredient: DEZOCINE
Proprietary Name: DALGAN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019082
Product Number: 002
Approval Date: Dec 29, 1989
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
DALGAN (DEZOCINE)
15MG/ML
Marketing Status: Discontinued
Active Ingredient: DEZOCINE
Proprietary Name: DALGAN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 15MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019082
Product Number: 003
Approval Date: Dec 29, 1989
Applicant Holder Full Name: ASTRAZENECA LP
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top